Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Delay in Clearance of Labeled Protons in Patients with Acute Head Trauma Utilizing MRI 3D TGSE PASL MRI (Arterial Spin Labeling)

Author:Kang, Jubin   Zivcevska, Marija   Grohol, Bryce   Clark, Bradley   Dorman, Ian   Lencke, Josh   Arrasmith, Connor   Kim, Stephan   Rich, Ethan   Joseph, Charles   

Session Name:P8: Neuro Trauma and Sports Neurology  

Topic:Neuro Trauma and Sports Neurology  

Program Number:P8.007  

Author Institution:Liberty University College of Osteopathic Medicine, Lynchburg, VA  

Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: Second Interim Analysis of the Observational PEARL Study

Author:Ashina, Messoud   Mitsikostas, Dimos Dimitrios   Amin, Faisal   Kokturk, Pinar   Sahin, Gurdal   Schankin, Christoph J   Dorman, Paul J   Pozo-Rosich, Patricia   Lyras, Leonidas   Myers, Coleen   Ahn, Andrew H   Tassorelli, Cristina   

Session Name:P12: Headache: Clinical Trials and Real World Studies 2  

Topic:Headache  

Program Number:P12.002  

Author Institution:IRCCS Mondino Foundation, University of Pavia, Pavia, Italy , Pavia, Italy  Danish Headache Center, University of Copenhagen, Rigshopitalet, Copenhagen, Denmark  Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece  Danish Headache Center, University of Copenhagen, Rigshopitalet, Department of Neurorehabilitation/Traumatic Brain Injury, Righospitalet, University of Copenhagen, Copenhagen, Denmark  Department of Clinical Sciences of Lund, Lund University, Skåneuro Neurology Clinic, Copenhagen, Denmark  Teva Netherlands B.V., Amsterdam, Netherlands  Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland  Headache Unit & Research Group, Vall d’Hebron Hospital & Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA  The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom  

Black Patients with Movement Disorders Less Likely to Receive Treatment with Deep Brain Stimulation

Author:Dorritie, Andrew   Faysel, Mohammad   Gruessner, Angelika   Robakis, Daphne   

Session Name:S29: Health Care Disparities  

Topic:Health Care Disparities  

Program Number:S29.001  

Author Institution:SUNY Downstate Medical Center, Brooklyn, NY  

Loss of gyrification is associated with disability progression in multiple sclerosis

Author:Dos Santos Silva, Jonadab   La Rosa, Francesco   Mullins, William A   Parvathaneni, Prasanna   Maranzano, Josefina   Reich, Daniel   Beck, Erin   

Session Name:P10: MS Neuroimaging 1  

Topic:MS and Inflammatory Disease  

Program Number:P10.006  

Author Institution:Icahn School of Medicine at Mount Sinai, New York, NY  National Institutes of Health, Bethesda, MD  McGill University, Montreal Neurological Institute, Montreal, QC, Canada  National Institutes of Health, Neuroimmunology Branch, NINDS, Bethesda, MD  

Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis

Author:Venkatesh, Shruthi   Riley, Claire   Dhand, Amar   Doshi, Nandini   Kavak, Katelyn   Levit, Elle   Perrone, Christopher   Weinstock-Guttman, Bianca   Longbrake, Erin   De Jager, Philip   Xia, Zongqi   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.001  

Author Institution:University of Pittsburgh, Pittsburgh, PA  Columbia University Irving Medical Center, New York, NY  Brigham and Women's Hospital, Boston, MA  Jacobs MS Treatment and Research Center, Buffalo, NY  Yale University, Burlington, VT  University of Pennsylvania, Philadelphia, PA  Yale University, New Haven, CT